Cambodia vs Costa Rica: Cause of death, by non-communicable diseases, male
Cambodia
60.2%
in 2021
Costa Rica
60.8%
in 2021
Cambodia rank
93rd
Costa Rica rank
90th
Cause of death, by non-communicable diseases, male over time
- Cambodia
- Costa Rica
How they compare
Costa Rica currently reports 60.8% against 60.2% in Cambodia, a difference of 0.6%.
Across all 6 years both countries report, Costa Rica has been ahead every year.
Cambodia ranks 93rd and Costa Rica ranks 90th of 185 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.7% | 73.6% | 38.0% | Costa Rica |
| 2010s | 60.5% | 76.3% | 15.8% | Costa Rica |
| 2020s | 64.0% | 66.8% | 2.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Cambodia or Costa Rica?
- Costa Rica, at 60.8% against 60.2% in Cambodia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Cambodia and Costa Rica?
- 0.6%, with Costa Rica ahead.
- How many years of comparable data are there for Cambodia and Costa Rica?
- 6 years are reported by both, from 2000 to 2021.
- How do Cambodia and Costa Rica rank globally for cause of death, by non-communicable diseases, male?
- Cambodia ranks 93rd and Costa Rica ranks 90th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.